Drug major Cipla has inked a pact to acquire 11.71 per cent stake in Wellthy Therapeutics for a cash consideration of Rs 10.5 crore. As part of the deal, the partners plan to offer a combination of pharmacotherapy and digital therapeutics for improved patient outcomes in the chronic therapies of diabetology and cardiology.